Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,714 shares (to pay taxes)
  4. 4 Grant or award Chief Legal Officer acquired 100,000 shares (grant or award)
  5. 4 Planned sale President and CEO sold 8,257 shares at $4.29 ($35,413)
  6. 4 Shares withheld for taxes SVP, Regulatory Affairs gave up 1,667 shares (to pay taxes)
  7. 4 Shares withheld for taxes Corporate Secretary gave up 135,690 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief People Officer gave up 56,778 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 335,922 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 92,652 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Operating Officer gave up 72,734 shares (to pay taxes)
  12. 4 Shares withheld for taxes Corporate Secretary gave up 76,147 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Chief People Officer sold 29,814 shares at $4.17 ($124,414)

Page 2 of 17 · 325 filings